Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz, 55128, Germany.
Adv Healthc Mater. 2022 Jan;11(2):e2101854. doi: 10.1002/adhm.202101854. Epub 2021 Nov 19.
Uncontrolled amyloid-beta (Aβ) fibrillation leads to the deposition of neurotoxic amyloid plaques and is associated with Alzheimer's disease. Inhibiting Aβ monomer fibrillation and dissociation of the formed fibers is regarded as a promising therapeutic strategy. Here, amphiphilic polyphenylene dendrons (APDs) are demonstrated to interrupt Aβ assembly and reduce Aβ-cell interactions. Containing alternating negatively charged sulfonic acid and hydrophobic n-propyl peripheral groups, APDs bind to the secondary structure of the Aβ aggregates, inhibiting fibrillation and disassemble the already formed Aβ fibrils. APDs reveal vesicular cellular uptake in endosomes as well as cell compatibility for endothelial and neuronal cells, and significantly reduce Aβ-induced neuron cytotoxicity in vitro. Moreover, they are transported into the brain and successfully cross the blood-brain barrier after systemic application in mice, indicating their high potential to inhibit Aβ fibrillation in vivo, which can be beneficial for developing therapeutic strategy for Alzheimer's disease.
未控制的淀粉样蛋白-β(Aβ)纤维形成导致神经毒性淀粉样斑块的沉积,与阿尔茨海默病有关。抑制 Aβ单体纤维形成和已形成纤维的解离被认为是一种有前途的治疗策略。在这里,两亲性聚对苯撑树状大分子(APDs)被证明可以打断 Aβ 组装并减少 Aβ-细胞相互作用。APDs 含有交替的带负电荷的磺酸和疏水性正丙基外围基团,与 Aβ 聚集体的二级结构结合,抑制纤维形成并使已形成的 Aβ 纤维解聚。APDs 在内涵体中显示出囊泡状细胞摄取以及对内皮细胞和神经元细胞的细胞相容性,并显著降低体外 Aβ 诱导的神经元细胞毒性。此外,它们在全身给药后能够进入小鼠的大脑并成功穿过血脑屏障,表明它们在体内抑制 Aβ 纤维形成的潜力很高,这可能有助于开发阿尔茨海默病的治疗策略。